Gore Range Capital
Overview
Gore Range Capital is a venture capital firm focused on hands-on investing in early-stage healthcare businesses where it can offer not just capital but insights . The firm is focused on investments in early-stage skin health businesses . Gore Range Capital blends the hands-on approach of operationally focused private equity with the early-stage guidance needed in venture capital .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Palvella Therapeutics | Dec 2024 | Private Placement | Co-investor |
| AOA Dx | Oct 2023 | Series A | Co-investor |
| NovaScan Inc. | Nov 2021 | Series B | Co-investor |
| Sagesse Bio, Inc. | Jul 2024 | Joint Venture | Co-investor |
| Dorsata | Apr 2020 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Gore Range Capital based?
Gore Range Capital is headquartered in New York City, New York, United States.
When was Gore Range Capital founded?
Gore Range Capital was founded in 2015.
How many portfolio companies does Gore Range Capital have?
Gore Range Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Gore Range Capital's portfolio?
Portfolio companies visible on Caplight include Palvella Therapeutics, AOA Dx, NovaScan Inc., Sagesse Bio, Inc., Dorsata.
What was Gore Range Capital's most recent investment shown here?
Gore Range Capital's most recent investment in this portfolio sample was in Palvella Therapeutics in 2024.
What sectors does Gore Range Capital focus on?
Gore Range Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does Gore Range Capital focus on?
Stage focus information for Gore Range Capital is not publicly available.
What is Gore Range Capital's AUM?
Gore Range Capital's assets under management are estimated between $50.0M and $100.0M.